ITOS - iTeos Therapeutics, Inc.

QQQ $ 480.15 $ -1.01 (-0.21 %)

DIA $ 408.54 $ -0.55 (-0.13 %)

SPY $ 558.65 $ -0.91 (-0.16 %)

TLT $ 98.68 $ 0.78 (0.8 %)

GLD $ 232.46 $ 0.85 (0.37 %)

Previous Close

$ 17.5

Open

Bid

$ 17.46 x 105

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 8.20 - $ 18.75

Volume

406,792

Average Volume

Market Cap

694.73M

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-10-2024	03-31-2024	10-Q
3	03-06-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-15-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-23-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-11-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-24-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	09-01-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

iTeos Therapeutics Announces Interim Data ...
08/20/2024 12:40:10

Wells Fargo Initiates Coverage On ITeos Th...
08/13/2024 11:09:33

Wells Fargo analyst Eva Fortea Verdejo initiates coverage on ITeos Therapeutics (NASDAQ:ITOS) with a Overweight rating and a...

JP Morgan Maintains Overweight on ITeos Th...
08/12/2024 14:38:28

JP Morgan analyst Brian Cheng maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from ...

ITeos Therapeutics Q2 2024 GAAP EPS $(0.18...
08/08/2024 12:17:34

iTeos Therapeutics Has Dosed First Patient...
07/08/2024 11:18:14

This event has triggered $35 million in development milestone payments from GSK, its partner for belrestotug. iTeos and GSK en...

iTeos And GSK Initiate GALAXIES Lung-301 P...
06/17/2024 13:07:19

iTeos Therapeutics, Inc. (NASDAQ:ITOS) ("iTeos"), a clinical-stage biopharmaceutical company pioneering the discovery a...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
05/28/2024 17:35:22

HC Wainwright & Co. Maintains Buy on ITeos...
05/13/2024 11:16:46

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ITeos Therapeutics (NASDAQ:ITOS) with a Buy and raises the ...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
05/10/2024 16:31:07

genpact-posts-upbeat-earnings-joins-groupon-natera-funko-cargurus-and-other-big-stocks-moving-higher-on-friday

Genpact Posts Upbeat Earnings, Joins Group...
05/10/2024 14:48:27

dow-jumps-over-100-points-dnow-posts-downbeat-earnings

Dow Jumps Over 100 Points; DNOW Posts Down...
05/10/2024 14:00:59

Market-Moving News for May 10th
05/10/2024 12:41:27

ITOS: 39% | iTeos Therapeutics shares are trading higher after the company announced a $120 million registered direct offering ...

ITeos Therapeutics Expects Topline Data Fr...
05/10/2024 12:29:03

Iteos Therapeutics Announces $120M Registe...
05/10/2024 12:27:41

ITeos Therapeutics Q1 2024 GAAP EPS $(1.07...
05/10/2024 12:27:39

ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of ...

Reported Earlier, iTeos To Present EOS-984...
04/08/2024 06:26:00

JP Morgan Maintains Overweight on ITeos Th...
03/12/2024 13:09:47

JP Morgan analyst Brian Cheng maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from ...

HC Wainwright & Co. Reiterates Buy on ITeo...
03/07/2024 12:27:39

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains ...

Recap: ITeos Therapeutics Q4 Earnings
03/06/2024 14:00:17